- Inhibitor of PCSK9 protein - alirocumab in clinical trials, ODYSSEY program2018 | First Faculty of Medicine
- Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial2019 | Publication without faculty affiliation
- Low concentration of plasma cholesterol and type 2. diabetes mellitus2021 | First Faculty of Medicine